Dynamic FDG-PET imaging for differentiating metastatic from non-metastatic lymph nodes of lung cancer

OBJECTIVES: (18)F-fluorodeoxyglucose (FDG) PET/CT has been widely used in tumor diagnosis, staging, and response evaluation. To determine an optimal therapeutic strategy for lung cancer patients, accurate staging is essential. Semi-quantitative standardized uptake value (SUV) is known to be affected...

Descripción completa

Detalles Bibliográficos
Autores principales: Wumener, Xieraili, Zhang, Yarong, Wang, Zhenguo, Zhang, Maoqun, Zang, Zihan, Huang, Bin, Liu, Ming, Huang, Shengyun, Huang, Yong, Wang, Peng, Liang, Ying, Sun, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686335/
https://www.ncbi.nlm.nih.gov/pubmed/36439506
http://dx.doi.org/10.3389/fonc.2022.1005924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686335/
https://www.ncbi.nlm.nih.gov/pubmed/36439506
http://dx.doi.org/10.3389/fonc.2022.1005924

Ejemplares similares